VYGR
Voyager Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.51
+3.85%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+3.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 11, 2026 | Vitale Nancy · director | A-Award | 30,000 | $3.43 |
| Jun 11, 2026 | Hyman Steven · director | A-Award | 30,000 | $3.43 |
| Jun 11, 2026 | MACKEY CATHERINE J · director | A-Award | 30,000 | $3.43 |
| Jun 11, 2026 | SCANGOS GEORGE A · director | A-Award | 30,000 | $3.43 |
| Jun 11, 2026 | PIERCE GLENN · director | A-Award | 30,000 | $3.43 |
| Jun 11, 2026 | Colon Grace · director | A-Award | 30,000 | $3.43 |
| Jun 11, 2026 | GERAGHTY JAMES A · director | A-Award | 30,000 | $3.43 |
| Jun 11, 2026 | Onyia Jude · director | A-Award | 30,000 | $3.43 |
| Jun 11, 2026 | Higgins Michael J · director | A-Award | 30,000 | $3.43 |
| Apr 3, 2026 | Shiferman Gregory L. · officer: SVP and General Counsel | A-Award | 50,000 | $0.00 |
| Apr 3, 2026 | Sandrock Alfred · director, officer: President and CEO | Sale | 11,511 | $3.87 |
| Feb 26, 2026 | Swartz Robin · officer: COO & CBO | Sale | 6,458 | $3.77 |
| Feb 26, 2026 | Carter Todd Alfred · officer: Chief Scientific Officer | Sale | 4,174 | $3.76 |
| Feb 26, 2026 | Jorgensen Nathan D. · officer: Chief Financial Officer | Sale | 4,668 | $3.77 |
| Feb 26, 2026 | Sandrock Alfred · director, officer: President and CEO | Sale | 14,197 | $3.79 |
| Feb 20, 2026 | Carter Todd Alfred · officer: Chief Scientific Officer | Sale | 3,301 | $3.44 |
| Feb 20, 2026 | Sandrock Alfred · director, officer: President and CEO | Sale | 11,732 | $3.41 |
| Feb 20, 2026 | Swartz Robin · officer: COO & CBO | Sale | 3,882 | $3.44 |
| Feb 11, 2026 | Sandrock Alfred · director, officer: President and CEO | Sale | 12,192 | $3.78 |
| Feb 11, 2026 | Swartz Robin · officer: COO & CBO | Sale | 4,569 | $3.85 |
| Feb 11, 2026 | Carter Todd Alfred · officer: Chief Scientific Officer | Sale | 3,525 | $3.85 |
| Feb 10, 2026 | Jorgensen Nathan D. · officer: Chief Financial Officer | A-Award | 32,250 | $0.00 |
| Feb 10, 2026 | Ferguson Toby · officer: Chief Medical Officer | A-Award | 210,000 | $3.68 |
| Feb 10, 2026 | Ferguson Toby · officer: Chief Medical Officer | A-Award | 45,000 | $0.00 |
| Feb 10, 2026 | Carter Todd Alfred · officer: Chief Scientific Officer | A-Award | 33,000 | $0.00 |
| Feb 10, 2026 | Carter Todd Alfred · officer: Chief Scientific Officer | A-Award | 154,000 | $3.68 |
| Feb 10, 2026 | Swartz Robin · officer: COO & CBO | A-Award | 45,000 | $0.00 |
| Feb 10, 2026 | Swartz Robin · officer: COO & CBO | A-Award | 210,000 | $3.68 |
| Feb 10, 2026 | Sandrock Alfred · director, officer: President and CEO | A-Award | 86,250 | $0.00 |
| Feb 10, 2026 | Sandrock Alfred · director, officer: President and CEO | A-Award | 402,500 | $3.68 |
Institutional positioning
13F filings over the trailing two quarters
New 28Increased 45Reduced 42Sold out 132
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 5,568,381 | May 13, 2026 |
| ARMISTICE CAPITAL, LLC | Reduced | 3,500,000 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 3,428,571 | May 15, 2026 |
| VESTAL POINT CAPITAL, LP | Increased | 3,002,936 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,283,253 | May 15, 2026 |
| OPALEYE MANAGEMENT INC. | Reduced | 1,150,000 | May 15, 2026 |
| ERSTE ASSET MANAGEMENT GMBH | Reduced | 1,095,141 | May 11, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 1,049,978 | May 15, 2026 |
| STATE STREET CORP | Increased | 948,226 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 890,467 | Sep 2, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 875,568 | May 7, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 725,769 | May 8, 2026 |
| MORGAN STANLEY | Reduced | 681,711 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 615,660 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 578,024 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 11, 2026